Sort
30,917 grants matching “tumor microenvironment”
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
$301,885Li Lily Wang · Medical College Of Wisconsin · R01 · FY2017 · CA
Development of a B Cell Based Vaccine for the Treatment of Newly Diagnosed Malignant Gliomas
$301,832Catalina Lee Chang · Northwestern University At Chicago · P50 · FY2023 · CA
Targeting Deubiquitylating Enzymes in Multiple Myeloma
$301,819Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2014 · CA
Project 4: Combined use of immunotherapy and targeted treatments for triple negative breast cancer
$301,775Kornelia Polyak · Dana-Farber Cancer Inst · P50 · FY2023 · CA
Microenvironment: Imaging/Implications in Brain Tumors
$301,754Sydney M Evans · University Of Pennsylvania · R01 · FY2006 · CA
Modifying mTOR signaling to enhance immune mediated clearance of HPV+ HNSCC
$301,668John H Lee · Sanford Research/Usd · P20 · FY2020 · GM
The Regulation of Tumor Progression by Endothelial HoxA5
$301,641Nancy J Boudreau · University Of California, San Francisco · R01 · FY2014 · CA
Integrating innate and adaptive immunity in cancer therapy
$301,618Nejat K Egilmez · University Of Louisville · R01 · FY2014 · CA
Time-restricted feeding and breast cancer
$301,592Nicholas J Webster · University Of California, San Diego · R01 · FY2024 · CA
Targeting Cathepsin L: A Novel Strategy to Impede Prostate and Breast Cancer Meta
$301,578Dietmar W Siemann · University Of Florida · R01 · FY2014 · CA
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
$301,545Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
$301,545Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
$301,545Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
$301,545Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2014 · CA
An Orthotopic Murine Model of HCC: Immunotolerance and Prevention
$301,525Kevin Finnbar Staveleyo'carroll · University Of Missouri-Columbia · R01 · FY2016 · CA
Estrogen Receptor Alpha Proteostasis in Breast Cancer
$301,522Elaine T Alarid · University Of Wisconsin-Madison · R01 · FY2014 · CA
Regulation and targeting of tumor cell states and plasticity in pancreatic cancer
$301,496Srivatsan Raghavan · Dana-Farber Cancer Inst · K08 · FY2024 · CA
Regulation and targeting of tumor cell states and plasticity in pancreatic cancer
$301,496Srivatsan Raghavan · Dana-Farber Cancer Inst · K08 · FY2023 · CA
Regulation and targeting of tumor cell states and plasticity in pancreatic cancer
$301,496Srivatsan Raghavan · Dana-Farber Cancer Inst · K08 · FY2025 · CA
Novel developmental regulation of non-canonical Wnt signaling
$301,445Jan L Christian · University Of Utah · R01 · FY2015 · HD
Mechanisms of Cell-Cell Interaction in Tumor Growth and Metastasis in Flies
$301,440Tian Xu · Yale University · R01 · FY2012 · CA
Integrative and Quantitative Biosciences Accelerated Training Environment
$301,431Peng Qiu · Georgia Institute Of Technology · T32 · FY2023 · GM
Project 2: Measuring and modeling the tumor and immune microenvironment before and during therapy and at the time of drug resistance
$301,411Arlene H Sharpe · Harvard Medical School · U54 · FY2022 · CA
Biopolymer-based strategies for local delivery of cytokine therapeutics
$301,389David Zaharoff · University Of Arkansas At Fayetteville · R01 · FY2014 · CA
TRD1: Functional Imaging
$301,386Nestor Uribe-Patarroyo · Massachusetts General Hospital · P41 · FY2023 · EB